Expression of Interferon Regulatory Factor Family and its Prognostic value in Acute Myeloid Leukemia

References

• Short NJ , RyttingME, CortesJE. Acute myeloid leukaemia. Lancet392(10147), 593–606 (2018).
   PubMed Web of Science ®Google Scholar
• Sakaguchi M , YamaguchiH, NajimaYet al. Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia. Blood Adv.2(20), 2744–2754 (2018).
   PubMed Web of Science ®Google Scholar
• Pratcorona M , BrunetS, NomdedeuJet al. Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. Blood121(14), 2734–2738 (2013).
   PubMed Web of Science ®Google Scholar
• Wouters BJ , LowenbergB, Erpelinck-VerschuerenCA, Van PuttenWL, ValkPJ, DelwelR. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood113(13), 3088–3091 (2009).
   PubMed Web of Science ®Google Scholar
• Schnittger S , DickerF, KernWet al. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Blood117(8), 2348–2357 (2011).
   PubMed Web of Science ®Google Scholar
• Pratcorona M , AbbasS, SandersMAet al. Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value. Haematologica97(3), 388–392 (2012).
   PubMed Web of Science ®Google Scholar
• Fathi AT , ChenYB. Treatment of FLT3-ITD acute myeloid leukemia. Am. J. Blood Res.1(2), 175–189 (2011).
   PubMedGoogle Scholar
• Bowen D , GrovesMJ, BurnettAKet al. TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia23(1), 203–206 (2009).
   PubMed Web of Science ®Google Scholar
• Prada-Arismendy J , ArroyaveJC, RothlisbergerS. Molecular biomarkers in acute myeloid leukemia. Blood Rev.31(1), 63–76 (2017).
   PubMed Web of Science ®Google Scholar
• Xu B , SongX, YipNCet al. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia. Hematology15(2), 74–80 (2010).
   PubMed Web of Science ®Google Scholar
• Xutao G , PengchengS, YinLet al. BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy. Pharmacogenomics19(4), 343–348 (2018).
   PubMed Web of Science ®Google Scholar
• Guo X , ShiP, ChenFet al. Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome. Blood Cells Mol. Dis.53(3), 144–148 (2014).
   PubMed Web of Science ®Google Scholar
• Tamura T , YanaiH, SavitskyD, TaniguchiT. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol.26, 535–584 (2008).
   PubMed Web of Science ®Google Scholar
• Taniguchi T , OgasawaraK, TakaokaA, TanakaN. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol.19, 623–655 (2001).
   PubMed Web of Science ®Google Scholar
• Paun A , PithaPM. The IRF family, revisited. Biochimie89(6–7), 744–753 (2007).
   PubMed Web of Science ®Google Scholar
• Mancino A , NatoliG. Specificity and function of IRF family transcription factors: insights from genomics. J. Interferon Cytokine Res.36(7), 462–469 (2016).
   PubMed Web of Science ®Google Scholar
• Zhao GN , JiangDS, LiH. Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. Biochim. Biophys. Acta1852(2), 365–378 (2015).
   PubMed Web of Science ®Google Scholar
• Chen YJ , LiJ, LuN, ShenXZ. Interferon regulatory factors: a key to tumour immunity. Int. Immunopharmacol.49, 1–5 (2017).
   PubMed Web of Science ®Google Scholar
• Mei Z , WangG, LiangZet al. Prognostic value of IRF-2 expression in colorectal cancer. Oncotarget8(24), 38969–38977 (2017).
   PubMedGoogle Scholar
• Connett JM , BadriL, GiordanoTJ, ConnettWC, DohertyGM. Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays. J. Interferon Cytokine Res.25(10), 587–594 (2005).
   PubMed Web of Science ®Google Scholar
• Hochhaus A , YanXH, WillerAet al. Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia. Leukemia11(7), 933–939 (1997).
   PubMed Web of Science ®Google Scholar
• Manzella L , TirroE, PennisiMSet al. Roles of interferon regulatory factors in chronic myeloid leukemia. Curr. Cancer Drug Targets16(7), 594–605 (2016).
   PubMed Web of Science ®Google Scholar
• Green WB , SlovakML, ChenIM, PallaviciniM, HechtJL, WillmanCL. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31). Leukemia13(12), 1960–1971 (1999).
   PubMed Web of Science ®Google Scholar
• Tian WL , JiangZX, WangFet al. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155. Biochem. Biophys. Res. Commun.478(3), 1130–1135 (2016).
   PubMed Web of Science ®Google Scholar
• Pogosova-Agadjanyan EL , KopeckyKJ, OstronoffFet al. The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia. PLOS ONE8(8), e70812 (2013).
   PubMed Web of Science ®Google Scholar
• Tang Z , LiC, KangB, GaoG, LiC, ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.45(W1), W98–W102 (2017).
   PubMed Web of Science ®Google Scholar
• Li W , CowleyA, UludagMet al. The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic Acids Res.43(W1), W580–W584 (2015).
   PubMed Web of Science ®Google Scholar
• Vasaikar SV , StraubP, WangJ, ZhangB. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res.46(D1), D956–D963 (2018).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N , LeyTJ, MillerCet al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med.368(22), 2059–2074 (2013).
   PubMed Web of Science ®Google Scholar
• Budczies J , KlauschenF, SinnBVet al. Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLOS One7(12), e51862 (2012).
   PubMed Web of Science ®Google Scholar
• Alsamman K , El-MasryOS. Interferon regulatory factor 1 inactivation in human cancer. Biosci. Rep.38(3), BSR20171672 (2018).
   PubMedGoogle Scholar
• Jeyakumar T , FodilN, VanDer Kraak Let al. Inactivation of interferon regulatory factor 1 causes susceptibility to colitis-associated colorectal cancer. Sci. Rep.9(1), 18897 (2019).
   PubMedGoogle Scholar
• Wei Y , ChenX, YangJet al. DcR3 promotes proliferation and invasion of pancreatic cancer via a DcR3/STAT1/IRF1 feedback loop. Am. J. Cancer Res.9(12), 2618–2633 (2019).
   PubMed Web of Science ®Google Scholar
• Alsamman K , ZhangX, VatteCet al. Novel IRF-1 mutations in a small cohort of leukaemia patients from Saudi Arabia. Asian Pac. J. Cancer Prev.18(10), 2795–2801 (2017).
   PubMedGoogle Scholar
• Preisler HD , PerambakamS, LiBet al. Alterations in IRF1/IRF2 expression in acute myelogenous leukemia. Am. J. Hematol.68(1), 23–31 (2001).
   PubMed Web of Science ®Google Scholar
• Guzman ML , UpchurchD, GrimesBet al. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood97(7), 2177–2179 (2001).
   PubMed Web of Science ®Google Scholar
• Ikushima H , NegishiH, TaniguchiT. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol.78, 105–116 (2013).
   PubMedGoogle Scholar
• Ning S , PaganoJS, BarberGN. IRF7: activation, regulation, modification and function. Genes Immun.12(6), 399–414 (2011).
   PubMed Web of Science ®Google Scholar
• Tang XD , ZhangDD, JiaL, JiW, ZhaoYS. lncRNA AFAP1-AS1 promotes migration and invasion of non-small cell lung cancer via up-regulating IRF7 and the RIG-I-Like receptor signaling pathway. Cell Physiol. Biochem.50(1), 179–195 (2018).
   PubMedGoogle Scholar
• Peng S , WangG, ChengZ, GuoZ. IRF7 as an immune-related prognostic biomarker and associated with tumor microenvironment in low-grade glioma. Int. J. Gen. Med.14, 4381–4393 (2021).
   PubMed Web of Science ®Google Scholar
• Paul A , TangTH, NgSK. Interferon regulatory factor 9 structure and regulation. Front. Immunol.9, 1831 (2018).
   PubMed Web of Science ®Google Scholar
• Tian WL , GuoR, WangFet al. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia. Exp. Cell Res.365(2), 185–193 (2018).
   PubMed Web of Science ®Google Scholar